Compare BLCO & PIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLCO | PIPR |
|---|---|---|
| Founded | 1853 | 1895 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 4.9B |
| IPO Year | 2022 | 2003 |
| Metric | BLCO | PIPR |
|---|---|---|
| Price | $16.71 | $75.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 3 |
| Target Price | $18.45 | ★ $91.38 |
| AVG Volume (30 Days) | 417.0K | ★ 588.1K |
| Earning Date | 04-29-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 2.26% |
| EPS Growth | N/A | ★ 54.49 |
| EPS | N/A | ★ 0.92 |
| Revenue | ★ $5,101,000,000.00 | $1,904,217,000.00 |
| Revenue This Year | $8.65 | $12.30 |
| Revenue Next Year | $5.59 | $13.55 |
| P/E Ratio | ★ N/A | $82.17 |
| Revenue Growth | 6.47 | ★ 24.33 |
| 52 Week Low | $13.53 | $69.16 |
| 52 Week High | $18.92 | $380.26 |
| Indicator | BLCO | PIPR |
|---|---|---|
| Relative Strength Index (RSI) | 56.83 | 47.73 |
| Support Level | $16.74 | $75.40 |
| Resistance Level | $17.61 | $77.51 |
| Average True Range (ATR) | 0.54 | 2.91 |
| MACD | 0.05 | 0.21 |
| Stochastic Oscillator | 76.45 | 66.45 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities, and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services.